Suscribirse

Above–the–knee amputation versus knee arthrodesis for revision of infected total knee arthroplasty: Recurrent infection rates and functional outcomes of 43 patients at a mean follow-up of 6.7 years - 20/05/21

Doi : 10.1016/j.otsr.2021.102914 
Teddy Trouillez a, b, c, , Philippe Alexandre Faure a, b, c, Pierre Martinot a, b, c, Henri Migaud a, b, c, Eric Senneville a, c, d, Gilles Pasquier a, b, c, Julien Dartus a, b, c, Sophie Putman a, b, c
a Univ Lille, Hauts de France, 59000 Lille, France 
b Service d’orthopédie, Hôpital Salengro, Place de Verdun, CHU Lille, 59000 Lille, France 
c CRIOAC, Centre de Référence pour le traitement des Infections Ostéo-Articulaires Complexes Lille-Tourcoing, rue Emile Laine, 59000 Lille, France 
d Service de Maladie Infectieuses et du Voyageur, CH Dron, rue du Président Coty, 59208 Tourcoing, France 

Corresponding author at: Service d’orthopédie, Hôpital Salengro, Place de Verdun, CHU Lille, 59000 Lille, France.Service d’orthopédie, Hôpital Salengro, Place de Verdun, CHU LilleLille59000France

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
Artículo gratuito.

Conéctese para beneficiarse!

Abstract

Introduction

In cases of repeated treatment failure of periprosthetic joint infections (PJI) of the knee, above–the–knee amputation (AKA) or knee arthrodesis can be proposed to reduce the risk of recurrent infection, especially in cases with major bone defects or irreparable damage to the extensor mechanism of the knee. Since AKA versus knee arthrodesis results have been rarely assessed for these indications, we conducted a retrospective case-control study to compare both the rates of recurrent infection and functional outcomes.

Hypothesis Patients who underwent AKA had fewer recurrent infections than those who had arthrodesis.

Materials and methods

Twenty patients who underwent AKA and 23 patients who had knee arthrodesis, between 2003 and 2019, were retrospectively included in this study. These two groups were comparable in age (73.8 versus 77.7 years (p=.31)) and sex (10 women and 10 men versus 16 women and seven men (p=.19)). Each group was analyzed individually and then compared in terms of survival (recurrent infection) and functional outcomes using clinical assessment scores (visual analog scale (VAS), French neuropathic pain questionnaire (DN4), Parker and Palmer mobility score and the 36-item short-form survey (SF–36)).

Results

The rate of recurrent infection was 10% (two out of 20 patients) for the AKA group and 21.75% (five out of 23 patients) for the arthrodesis group (p=.69). The mean follow-up for the AKA group was 4.18 years (1.2-11.8) and 9.7 years (1.1-14.33) for the arthrodesis group (p=.002). The number of previous revisions (three (1.5-4) for AKA and two (2-3) for arthrodesis) and the time between the primary arthroplasty and surgical procedure were significantly greater in the AKA group (48.0 (12.0-102.0) months) than the arthrodesis group (48.0 (24.0-87.0) months) (p<001). The AKA group had significantly better clinical results for VAS (2.7±2.2 vs. 3.1±3.3), DN4 (1.5±2.1 vs. 2.6±2.9), Parker and Palmer (5.2±1.7 vs. 4.6±1.4), and SF–36 (30.9±15.6 vs. 26.9±17.0) (p<001).

Conclusion

Above–the–knee amputation and knee arthrodesis showed no differences in the rate of recurrent sepsis. However, the comparison of the two groups demonstrated that patients who underwent an AKA had less pain, were more autonomous and had a better quality of life.

Level of Evidence

III; retrospective case–control.

El texto completo de este artículo está disponible en PDF.

Keywords : Above–the–knee amputation, Knee arthrodesis, Periprosthetic joint infection, Septic revision surgery, Sepsis


Esquema


© 2021  Publicado por Elsevier Masson SAS.
Añadir a mi biblioteca Eliminar de mi biblioteca Imprimir
Exportación

    Exportación citas

  • Fichero

  • Contenido

Vol 107 - N° 4

Artículo 102914- juin 2021 Regresar al número
Artículo precedente Artículo precedente
  • Knee arthrodesis using a custom modular intramedullary nail in failed, infected knee arthroplasties: A concise follow-up note of 31 cases at a median of 13 years post-arthrodesis
  • Philippe-Alexandre Faure, Sophie Putman, Eric Senneville, Eric Beltrand, Héléne Behal, Henri Migaud
| Artículo siguiente Artículo siguiente
  • Extensor digitorum brevis muscle flap for lower extremity coverage in a context of posttraumatic sepsis
  • Aurore Woussen, Damien Feuvrier, Édouard Woussen, Julien Fageot, Pauline Sergent, Grégoire Leclerc, Laurent Obert, Isabelle Pluvy

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.

@@150455@@ Voir plus

Mi cuenta


Declaración CNIL

EM-CONSULTE.COM se declara a la CNIL, la declaración N º 1286925.

En virtud de la Ley N º 78-17 del 6 de enero de 1978, relativa a las computadoras, archivos y libertades, usted tiene el derecho de oposición (art.26 de la ley), el acceso (art.34 a 38 Ley), y correcta (artículo 36 de la ley) los datos que le conciernen. Por lo tanto, usted puede pedir que se corrija, complementado, clarificado, actualizado o suprimido información sobre usted que son inexactos, incompletos, engañosos, obsoletos o cuya recogida o de conservación o uso está prohibido.
La información personal sobre los visitantes de nuestro sitio, incluyendo su identidad, son confidenciales.
El jefe del sitio en el honor se compromete a respetar la confidencialidad de los requisitos legales aplicables en Francia y no de revelar dicha información a terceros.


Todo el contenido en este sitio: Copyright © 2026 Elsevier, sus licenciantes y colaboradores. Se reservan todos los derechos, incluidos los de minería de texto y datos, entrenamiento de IA y tecnologías similares. Para todo el contenido de acceso abierto, se aplican los términos de licencia de Creative Commons.